AllQuantitative Report
logoArgus•March 27, 2024

CHE: Lowering target price to $670.00

Symbols
CHE
Sector(s)
Healthcare
Rating
Current Price
$560.42
Price Target
Earnings Estimate
Summary

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade

Actions

Download Full Report

Related Reports

View more related reports